The Tale of Malignant Melanoma; a Tertiary Hospital Experience in South-South, Nigeria

International Journal of Medical Science

© 2018 by SSRG - IJMS Journal

Volume 5 Issue 6

Year of Publication : 2018

Authors : Akhator Terence Azeke and Dele Eradebamwen Imasogie

10.14445/23939117/IJMS-V5I6P103

How to Cite?

Akhator Terence Azeke and Dele Eradebamwen Imasogie, "The Tale of Malignant Melanoma; a Tertiary Hospital Experience in South-South, Nigeria," SSRG International Journal of Medical Science, vol. 5,  no. 6, pp. 9-14, 2018. Crossref, https://doi.org/10.14445/23939117/IJMS-V5I6P103

Abstract:

Introduction: Malignant melanomas are highly aggressive and invasive tumours with enormous metastatic potentials. The incidence is on the increase globally with resultant increase in its health burden (clinical and economical). It is therefore imperative that periodic data collection and analysis is necessary, to decipher the trend in relation to the findings of previous published study/studies. This will in no small measure give an insight on the health burden at that material point in time and also provide an avenue to plan and cushion the effect(s) that may arise from this burden. The aim of this study is therefore to elucidate the frequency, age and sex distribution of Malignant Melanoma in the University of Benin Teaching Hospital, Benin City Edo State, Nigeria. Methodology: A 10 year study that spanned from 1st of January, 2004 to 31st of December, 2013. The targets were all cases of malignant melanoma diagnosed during the period of study under review. Data obtained were analysed using the Statistical Package for Social Science version 16 (V. 16). Ethical clearance was duly obtained from the ethical review committee of the University of Benin Teaching Hospital. Results: Malignant melanomas accounted for 27 cases of the 187 cases of malignant skin tumours present during the study period. Their mean age was 52.96±22.04years (males =58.83years; females=48.27years), their age range was 3 – 111 years with a peak in the 7th decade. The male to female ratio was 1:1.3. The lower limb was the most frequent site of the tumour. Most cases were advanced stages of the disease (Clarks’s level 4 and 5). Conclusion: It accounts for 14% of malignant skin tumours. The females were slightly more affected than the males. The mean age in females was a decade less than that of their male counterpart. Their age range spanned from the 1st to the 12th decade. Most cases present late with advance disease.

Keywords:

 Malignant melanoma, health burden, tale, prevalence, peak age, mean age, male: female ratio

References:

[1] Alzolibani A, Al Shobaili HA, Robaee A, Khan A, Alrejaie A, Rao NS, et al. Clinical and histopathologic characteristics of skin malignancies in Qassim Region, Saudi Arabia. IJHS, Vol. 7, pp. 61-65, Jan. 2013 
[2] Laishram RS, Banerjee A, Punyabati P, Sharma DCL. Pattern of skin malignancies in Manipur, India: A 5-year histopathological review. Journal of Pakistan Association of Dermatologists, Vol. 20, pp. 128-132, 2010. [online]. Available at: http://jpad.com.pk/index.php/jpad/article/view/404/379 
[3] Muller M, Beck IM, Gadesmann J, Karschuk N, Paschen A, Proksch E, et al. MMP19 is upregulated during melanoma progression and increases invasion of the melanoma cells. Modern Pathology, Vol. 23, pp. 511-521, Jan. 2010 
[4] Rigel DS, Carucci JA. Malignant melanoma: prevention, early detection, and treatment in the 21st century. Ca Cancer J Clin, Vol. 50, pp. 215-36, Jan. 2000 
[5] Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. GLOBOCAN 2008 v12 Cancer Incidence and Mortality Worldwide: IARC Cancer base No10 [Internet] Lyon, France: International Agency for Research on Cancer; 2010.[online]. Available at: http://globocaniarcfr 
[6] Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. [online]. Available at: http://globocan.iarc.fr 
[7] Miller AJ, Minh MCJr. Melanoma. N Engl J Med, Vol. 355, pp. 51-56, Jul. 2006 
[8] Gerstenblith MR, Goldstein AM, Tucker MA, Fraser MC. Genetic testing for melanoma predisposition: current challenges. Cancer Nurs, Vol. 30, pp. 452-59, Nov. 2007 
[9] Lazar AJF, Murphy GF. The Skin, In: Robbins and Cotran Pathologic Basis of Disease, 8th edition. Philadelphia: Saunders Elsevier; 2010. 
[10] Lang PG. Current concepts in the management of patients with melanoma. Am J Clin Dermatol, Vol. 3, pp. 401-426, August 2002. 
[11] Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, et al. Malignant melanoma. An update. Arch Pathol Lab Med, Vol. 125, pp. 1295-1306. Oct. 2001 
[12] Adeyi O, Banjo A. Malignant Tumours of The Skin: A 6-Year Review of Histologically Diagnosed Cases (1990-1995). Nig Qt J Hosp Med, Vol. 8, pp. 99-102, 1998. [omline]. Available at: http://dx.doi.org/10.4314/nqjhm.v8i2.12607 
[13] Asuquo ME, Ebughe G. Cutaneous cancers in Calabar, Southern Nigeria. Dermatology Online Journal 2009; 15(4). [online] Available at : http://anagen.ucdavis.edu/1504/case_presentations/cutaneous_cancer/asuquo.html. 
[14] Datubo-Brown DD. Primary malignant skin tumors in Nigerians. J Natl Med Assoc, Vol. 83, pp. 345-358, April 1991 
[15] Forae GD, Olu-Eddo AN. Malignant Skin Tumors in Benin City, South-South, Nigeria. Oman Medical Journal, Vol. 28, pp. 311-315, Sep. 2013 
[16] Gana JY, Ademola SA. Skin malignancies in Ibadan: a comparative study. NJPS, Vol. 4, pp. 1-6, 2008. [online]. Available at: http://dx.doi.org/10.4314/njpsur.v4i1.40398 
[17] Mandong BM, Orkar KS, Sule AZ, Dakun NL. Malignant Skin Tumours in Jos University Teaching Hospital, Jos, Nigeria (Hospital Based Study). Nig J Surg Res, Vol. 3, pp. 29-33, 2001. [online]. Available at: http://dx.doi.org/10.4314/njsr.v3i1.12215 
[18] Mohammed AZ, Manasseh AN, Mandong BM, Edino ST. Histopathological study of malignant melanoma inhighlanders. Nig J Surg Res, Vol. 5, pp. 18-22. 2003. [online]. Available at: http://dx.doi.org/10.4314/njsr.v5i1.12140 
[19] Olu-Eddo AN, Forae GD. Morphologic Patterns Of Malignant Melanoma In Benin-City, South-South, Nigeria. EMJ, Vol. 1, pp. 63-68, 2012. [online]. Available at: https://www.ajol.info/index.php/ebomed/article/view/86315 
[20] Samaila MOA, Rafindadi AH. Pattern of Cutaneous Malignant Melanoma in Zaria, Nigeria. Ann Afri Med, Vol. 5, 19, 2006. [online]. Available at: http://www.bioline.org.br/abstract?am06004 
[21] Ukonu AB, Eze EU. Pattern of skin disease at the university of Benin teaching hospital, Benin city, Edo state, South-South Nigeria : a 12 month prospective study. Glob J Health Sci, Vol. 4, pp. 148-57. May 2012. 
[22] Ochicha O, Edino ST, Mohammed AZ, Umar AB. DERMATOLOGICAL MALIGNANCIES IN KANO, NORTHERN NIGERIA: A HISTOPATHOLOGICAL REVIEW. Ann Afri Med. Vol. 3, pp. 188-191, 2004. [online]. Available at: https://s3.amazonaws.com/academia.edu.documents/31841584/am04049.pdf?AWSAccessKeyId=AKIAIWOWYYGZ2Y53UL3A&Expires=1528829661&Signature=9qHa4jfmEweMVTCUawLf2%2FZDjqM%3D&response-content disposition=inline%3B%20filename%3DDERMATOLOGICAL_MALIGNANCIES_IN_KANO_NORT.pdf 
[23] Adu EJ, Annan C. Primary malignant skin tumours in Ghanaians: a prospective study of 31 cases. NJPS. [online]. Available at: http://dx.doi.org/10.4314/njpsur.v4i1.40399 
[24] Napo-Koura G, Pitche P, Tchangai-Walla K, James K, Kpodzro K. Cutaneous cancers in Togo. Bulletin du Cancer, Vol. 84, pp. 877-879, Oct. 1997. 
[25] Mseddi M, Marrekchi S, Abdelmaksoud W, Bouassida S, Meziou TJ. Epidemio-clinical profile of skin cancer in southern Tunisia. La Tunisie Medicale, Vol. 85, pp. 505-508, Jun. 2007. 
[26] Chalya PL, Gilyoma JM, Kanumba ES, Mawala B, Masalu N, et al. Dermatological malignancies at a University Teaching Hospital in Northwestren Tanzania: A retrospective review of 154 cases. Tanzanian Journal of Health Research. [online] Available at: http://dx.doi.org/10.4314%2Fthrb.v14i1.3 
[27] Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer, Vol. 78, pp. 78: 587-93, Nov. 1998. 
[28] Samaila MOA, Adewuyi SA. A histopathological analysis of cutaneous malignancies in a tropical African population. Njsr, Vol. 7, pp. 300-304. 2005 [online]. Available at: http://dx.doi.org/10.4314/njsr.v7i3.12302 
[29] LeBoit PE, Burg G, Weedon D, Sarasin A, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. IARC Press, lyon: 2006. 
[30] Seleye-Fubara D, Etebu E. Histological review of melanocarcinoma in Port Harcourt. Nigeria Journal of Clinical Practice, Vol. 8, pp. 110-113, Dec. 2005. 
[31] Weedon D. Weedon Skin Pathology, 3rd ed. China: Churchill Livingstone Elsevier; 2010. 
[32] Kossard S, Epstein EHJr, Cerio R, Yu LL, Weedon D. Basal Cell Carcinoma, In:World Health Organization Classification of Tumours Pathology and Genetics of Skin Tumours IARC Press, lyon: 2006. 
[33] Gattuso P, Spitz DJ, Reddy VB, David O, Haber MH (eds): Differential diagnosis in surgical pathology. Saunders Elseviers: Philadelphia 2010. 
[34] Barro-Traore F, Traore A, Konate I, Traore SS, Sawadogo NO, Sanou I, et al. Epidemiological features of tumours of the skin and mucosal membranes in the department of dermatology at the Yalgado Ouedraogo National hospital, Ouagadougou, Burkina Faso. Sante, Vol. 13, pp. 101-04, April 2003. 
[35] Onunu AN, Okoduwa C, Eze EU, Adeyekun AA, Kubeyinje EP, et al. Kaposi's sarcoma in Nigeria. Int J Dermatol, Vol. 46, pp. 264-67, Mar 2007. 
[36] Asuquo ME, Ogunkeyede A, Bassey EE, Ebughe G. Kaposi sarcoma: Changing trend in Calabar, south eastern Nigeria. Ann Afri Med, Vol. 7, pp. 98-101, Sep. 2008.